(No ratings)
Mrs. Jill S. Goldman, MPhil, MS is a null in New York, NY specializing in genetics and psychiatry & neurology. Mrs. Jill S. Goldman, MPhil, MS is affiliated with NewYork-Presbyterian, ColumbiaDoctors and CUIMC/Neurological Institute of New York.
Mrs. Jill S. Goldman, MPhil, MS appears to accept the following insurance providers: CIGNA, Magnacare (National), UnitedHealthcare, Healthspring (Cigna Medicare), World Trade Center Health Plan, United Healthcare PPO, United Healthcare POS, United Healthcare HMO, Great-West Healthcare, CIGNA PPO, CIGNA POS, Oxford HMO, United Healthcare, CIGNA HMO, CIGNA EPO and World Trade Center Health Plan - World Trade Center Health Plan.
According to our sources, Mrs. Jill S. Goldman, MPhil, MS accepts the following insurance providers:
Mrs. Jill S. Goldman, MPhil, MS does not have any reviews yet, be the first to leave a review of Mrs. Jill S. Goldman, MPhil, MS here: Leave a Review
(No ratings)
Jill Goldman is a Professor of Genetic Counseling in Neurology at Columbia University Irving Medical Center. She specializes in hereditary neurological diseases such as Alzheimer’s disease, frontotemporal degeneration, Parkinson’s disease, and Huntington’s disease. She is on the faculty of the Columbia University Master’s Program in Genetic Counseling. Additionally, she leads a support group for caregivers of people with frontotemporal dementia., She also created and coordinates “A Friend for Rachel”, a companionship program in which people with early to moderate dementia are paired with Columbia pre-medical students. Ms. Goldman has authored many papers and book chapters including: “Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors” (Genet Med. 2011). She is the editor of the textbook: Genetic Counseling for Adult Neurogenetic Disease: A Casebook for Clinicians, Springer, 2015. Ms. Goldman is an emeritus member of the medical advisory council of the Association for Frontotemporal Dementia (AFTD), present member of the Board of Directors of the AFTD, member of The European Huntington Disease Network Genetics Working Group and the AAN Science Committee Neurogenetics Expert Review Advisory Panel and a Board of Directors member of the AFTD.